This compound is primarily utilized in the field of biomedical research, particularly in the study of targeted protein degradation. It functions as a proteolysis-targeting chimera (PROTAC) designed to specifically degrade Sirtuin 2 (Sirt2), a protein implicated in various cellular processes and diseases. Researchers employ it to investigate the role of Sirt2 in conditions such as cancer, neurodegenerative disorders, and metabolic diseases. By selectively degrading Sirt2, it helps in understanding the protein's function and validating it as a potential therapeutic target. Its application also extends to drug discovery, where it serves as a tool to explore the efficacy of protein degradation strategies in developing novel treatments.